Can Organovo Keep It Up?

Organovo more than quadrupled last year, and it's up 17% in the past week.

Jan 6, 2014 at 9:25AM

Organovo (NYSEMKT:ONVO) is kicking off 2014 the same way that it closed out 2013: on fire.

The company hoping to create a proxy for human tissue that could be used to expedite drug testing -- with loftier organ-related aspirations down the line -- saw its stock soar 17% last week. The shares more than quadrupled last year as investors warmed up to Organovo's compelling story.

Organovo's 3-D bioprinting niche initially hopped on the 3-D printing bandwagon that's been en vogue since 2012. If we can now print physical objects on demand, why not genetic material, including tissue and organs? It's a fantastic scenario, yet the viability of Organovo's dream seemed years away. It helped make itself a rock star late last year when it pointed to the end of this year as its goal to roll out its first product. If this year's bioprinted liver tissue test is successful, heart and kidney tissue won't be too far away.

Soaring 326% over the past year, Organovo is packing a market cap of $842 million as it enters its first full week of trading in 2014. That may seem preposterous for a development-stage company with negligible revenue, but biotech and 3-D investors have shown that they're not afraid of taking a gamble.

An investment in Organovo is certainly not for the weak of heart. If it's successful in being the first company to market lab-created human tissue, drug companies will beat a path to its door. Organovo could be worth billions if not tens of billions. However, if it falls short -- or someone else beats it to the punch -- the stock's going to take a beating.

We won't have answers right away, but that will only make 2014 as volatile as the past year has been. We're months away from important tests that will hint at the feasibility of Organovo's faux liver tissue, but this is still a story that will take years -- not months -- to fully play out.

Organovo had a huge 2013, and it's likely to be more familiar to investors as 2014 plays out. That's saying something. Outside of the market's shortened trading day on Christmas Eve, you have to go back to mid-October to find the last time that less than a million shares traded hands.

It's going to be a lively year of trading for Organovo. Will its product follow suit? That's the multibillion-dollar question.

Another top stock to keep your eyes on
There's a huge difference between a good stock, and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it’s one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.


Longtime Fool contributor Rick Munarriz has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers